UNSPSC 51422406: Cloprednol

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H25ClO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SYP56O3GJG, chemically known as 6-chloro-11beta,17alpha, 21-trihydroxypregn-1,4,6-triene-3,20-dione but generally known as cloprednol, which bears US NIH Compound Identifier 21320. European Medicines Agency schedules Cloprednol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06744MIG.

UNSPSC 51422406 Cloprednol is a Commodity code that in recent state and local procurement activity has been applied to purchases of naloxone and drug deactivation systems for community health support. The code name and the actual work being solicited diverge substantially — the single recent opportunity in the source dataset tags a naloxone and safe drug deactivation system procurement under this code, but cloprednol is a corticosteroid pharmaceutical distinct from naloxone, an opioid antagonist. State and local procurement offices show minimal recent activity under this code, and the one available record appears to reflect a coding mismatch rather than genuine demand for cloprednol itself.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid response deadline was July 26, 2023, and the contract term included an initial two years with a one-year renewal option. The procurement required electronic bid submission, E-Verify compliance, drug-free workplace certification, and specific insurance coverage. The opportunity provides no signal of material recent demand for cloprednol as a pharmaceutical input to state or local operations. Firms pursuing genuine corticosteroid supply contracts should not rely on this code; the actual procurement activity under it appears limited to a single, miscoded naloxone solicitation.